<DOC>
	<DOCNO>NCT00488761</DOCNO>
	<brief_summary>Tigecycline 's activity resistant organism , well significant coverage gram-positive gram-negative bacteria , may provide valuable therapeutic alternative treating patient complicate skin and/or skin structure infection .</brief_summary>
	<brief_title>Study Evaluating Safety Efficacy Tigecycline Hospitalized Patients With cSSSI</brief_title>
	<detailed_description>To evaluate safety efficacy tigecycline treat hospitalized patient complicate skin and/or skin structure infection .</detailed_description>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Skin Diseases , Infectious</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Hospitalized male female patient , 18 year age old . Anticipated need intravenous antibiotic therapy 5 day longer . Patients know suspected complicate skin skin structure infection . Patients concomitant condition , opinion investigator , would preclude evaluation response make unlikely contemplated course therapy could complete . Patients severely impaired arterial blood supply insufficiency likelihood amputation infect anatomical site within one month likely . Infected diabetic foot ulcer decubitus ulcer infection present great one week 's duration chronically infected decubitus ulcer patient compliant measure necessary chronic wound healing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Tigecycline</keyword>
	<keyword>cSSSI</keyword>
	<keyword>complicate skin skin structure infection</keyword>
</DOC>